期刊文献+

Effects of Perindopril on Left Ventricular Remodeling and Osteopontin Expression in Rats With Myocardial Infarction 被引量:2

Effects of Perindopril on Left Ventricular Remodeling and Osteopontin Expression in Rats With Myocardial Infarction
下载PDF
导出
摘要 Objectives To observe the effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction. Methods In this study male adult SD rats were randomly divided into 3 groups: sham-operation group, MI-saline group and MI-perindopril group. Left anterior descending artery was ligated to generate myocardial infarction. Perindopril (2 mg/kg body weight/day) was administered from the next day of MI. Four weeks later, left ventricular diameter (LVEDD and LVESD) and left ventricular ejection fraction was estimated with echocardiography, LVSP, LVEDP and±dp/dtmax was detected with hemodynamic measurement, cardiomyocyte diameter and interstitial fibrosis infiltration were evaluated with histological methods, and myocardium osteopontin protein expression level was detected with western blot. Results ①Compared with the sham-operation group, all rats with MI developed significant systolic and diastolic dysfunction, as was indicated by decreased LVEF, LVSP and±dp/dtmax, as well as increased LVEDP. ②Rats with MI showed significantly dilated left ventricles and higher ventricular weight / body weight ratio, significantly increased cardiomyocyte diameter and marked interstitial fibrosis in the non-infarction area. ③Perindopril treatment partly prevented cardiac dysfunction and left ventricular remodeling as indicated by the parameters mentioned above. ④No osteopontin protein was detected in myocardium of sham-operation rats. In rats with MI, high level osteopontin protein expression was significantly inhibited by perindopril treatment. Conclusions In rats with MI, perindopril treatment significantly prevented left ventricular remodeling and myocardium osteopontin protein expression. Objectives To observe the effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction. Methods In this study male adult SD rats were randomly divided into 3 groups: sham-operation group, MI-saline group and MI-perindopril group. Left anterior descending artery was ligated to generate myocardial infarction. Perindopril (2 mg/kg body weight/day) was administered from the next day of MI. Four weeks later, left ventricular diameter (LVEDD and LVESD) and left ventricular ejection fraction was estimated with echocardiography, LVSP, LVEDP and±dp/dtmax was detected with hemodynamic measurement, cardiomyocyte diameter and interstitial fibrosis infiltration were evaluated with histological methods, and myocardium osteopontin protein expression level was detected with western blot. Results ①Compared with the sham-operation group, all rats with MI developed significant systolic and diastolic dysfunction, as was indicated by decreased LVEF, LVSP and±dp/dtmax, as well as increased LVEDP. ②Rats with MI showed significantly dilated left ventricles and higher ventricular weight / body weight ratio, significantly increased cardiomyocyte diameter and marked interstitial fibrosis in the non-infarction area. ③Perindopril treatment partly prevented cardiac dysfunction and left ventricular remodeling as indicated by the parameters mentioned above. ④No osteopontin protein was detected in myocardium of sham-operation rats. In rats with MI, high level osteopontin protein expression was significantly inhibited by perindopril treatment. Conclusions In rats with MI, perindopril treatment significantly prevented left ventricular remodeling and myocardium osteopontin protein expression.
出处 《South China Journal of Cardiology》 CAS 2007年第3期159-165,共7页 岭南心血管病杂志(英文版)
关键词 left ventricular remodeling osteopontin expression myocardial infarction RAT left ventricular remodeling osteopontin expression myocardial infarction rat
  • 相关文献

二级参考文献11

  • 1Liu YH,Xu J,Yang XP, et al. Effect of ACE inhibitors and angiotensin Ⅱ type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure. Hypertensin, 2002, 39: 375-381.
  • 2Mossion PB, Balligand JL.Modulation of cardiac contraction,relaxation and rate by the endothelial nitric oxide synthase (eNOS):lessons from genetically modified mice. J Physiol, 2003, 546: 63-75.
  • 3Koyanagi M, Egashira K, Kitamoto S, et al. Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis. Circulation, 2000, 102: 2243-2248.
  • 4Talukder MA, Fujiki T, Morikawa K. Endothelial nitric oxide synthase-independent effects of an ACEinhibition coronary flow response to bradykinin in aged mice. J Cardiovasc Pharmacol, 2004, 44: 557-563.
  • 5Xu J, Carretero OA, Liu YH, et al. Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice. Hepertension, 2002, 40: 244-250.
  • 6Brede M, Roell W, Ritter O, et al. Cardiac hypertrophy is associated with decreased eNOS expression in agiotensin AT2 receptor-deficient mice. Hypertension, 2003, 42:1177-1182.
  • 7Harada K, Sugaya T, Murakami K, et al. Angiotensin II type1 A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation, 1999, 100: 2093-2099.
  • 8Driss AB, Devaux C, Henrion D, et al. Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure. Circulation, 2000, 101: 2764-2770.
  • 9Ignijatovic T, Stanisavljevic S, Brovkovych V, et al. Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands. Mol Pharmacol, 2004, 66: 1301-1316.
  • 10Ohkubo N, Matsubara H, Nozawa Y, et al. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation, 1997, 96: 3954-3962.

共引文献7

同被引文献13

  • 1孙慧君,范江霖.心肌梗死动物模型研究的最新进展[J].中国动脉硬化杂志,2005,13(1):113-115. 被引量:7
  • 2李德,伍卫,周淑娴.FKBP12.6重组腺病毒载体的构建及其心肌细胞感染效率测定[J].中山大学学报(医学科学版),2006,27(3):271-275. 被引量:6
  • 3胡承恒,杨燕华,王小庆,伍贵富,杜志民,何小洪.人脐血单个核细胞移植对大鼠急性心肌梗死后血管再生的作用[J].中山大学学报(医学科学版),2006,27(4):391-395. 被引量:2
  • 4Levonen AL, Vahakangas E, Koponen JK, et al. Antioxidant gene therapy for cardiovascular disease: current status and future perspectives [J]. Circulation, 2008,117(16) : 2142-2150.
  • 5Vinge LE, Raake PW, Koch WJ. Gene therapy in heart failure [J]. Circ Res, 2008,102(12) : 1458-1470.
  • 6Vanhoutte D, Schcllings MW, Gotte M, et al. Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction [ J ]. Circulation, 2007,115 (4) : 475-482.
  • 7Stratford-Perricaudet LD, Makeh I, Perricaudet M, et al. Widespread long-term gene transfer to skeletal muscles and heart [J]. J Clin Invest, 1992,90(2): 626-630.
  • 8Meluzin J, Vlaon M, Groch L, et al. Intracoronary delivery of bone marrow cells to the acutely infarcted myocardium. Optimization of the delivery technique [J]. Cardiology, 2008, 112(2):98-106.
  • 9Cunningham JT, Bruno SB, Higgs KA, et al. Intrapericardial procaine affects volume expansion induced fos immunoreactivity in unanesthetized rats [J]. Exp Neurol, 2002,174(2) : 181-192.
  • 10Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA [J]. Hum Gene Ther, 1999, 10(10) : 1735-1737.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部